Artificial Intelligence

As Axos sets to reveal its Q2 results, investors weigh strong growth forecasts against mounting concerns over margin pressure and a shifting economy.

Profound Medical raises over $42M to advance its AI-powered, incision-free therapies for cancer and other diseases, signaling strong investor confidence.

As data centers face an energy crisis fueled by AI, Aradatum is commercializing a unique vertical wind turbine promising a dense, low-cost power solution.

Fresh off a successful IPO, Ceribell is set to showcase its revolutionary AI-powered EEG system, a device already changing outcomes in ICUs nationwide.

New Era Energy & Digital faces a major fraud lawsuit from New Mexico over abandoned oil wells, threatening its pivot to a high-tech data center future.

Transit-tech firm Argo gets a $1.4M boost from TheVentureCity, a fund led by a former Facebook colleague of Argo's CEO, to scale its smart city solutions.

The Emberly at Heritage Glen opens, combining advanced AI care monitoring with a people-first philosophy to meet Fort Worth’s growing senior care needs.

The biopharma investment giant has now acquired 100% of the royalty stream for Roche's blockbuster SMA drug, a strategic move years in the making.

HII delivers the advanced Ted Stevens (DDG 128), a Flight III destroyer with game-changing radar, bolstering U.S. naval power amid industrial challenges.

Veracyte prepares for the J.P. Morgan conference, where it will showcase its AI and genomic strategy amid strong financials and a competitive market.

The popular brunch chain is betting on a digital marketing guru to transform its customer experience and accelerate growth in a tech-driven market.

Facing stock pressure, Dot Ai bets on seasoned sales leader Delores Rochester to scale its enterprise business in the booming Asset Intelligence market.

The robotics firm is outsourcing key software development in a strategic move to reduce cash burn and speed its innovative surgical system to market.

Sweetgreen cashes out on its Infinite Kitchen tech, selling to Wonder for $186M. The deal signals a major shift in strategy and the food robotics industry.

The med-tech firm has submitted its AI-assisted capsule endoscopy module to the FDA, promising faster, more accurate, and accessible GI disease detection.

WISeKey's satellite arm, WISeSat, is merging with a SPAC to build a quantum-resilient IoT network, a key step in securing future global communications.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

A new trading course blends a data expert's system with a NYSE veteran's insight. But can it tame the high-stakes world of zero-DTE options?